The Miscellaneous Tariff Bill S.515/S. 610/H.R. 1260:  Patent Reform Act of 2009, all issues related to patent reform. H.R. 3200, America's Affordable Health Choices Act of 2009/ "America's Healthy Future Act" (unnumbered Senate bill), as it relates to new fees on manufacturers of drugs and medical devices and to taxation of employer-sponsored health coverage.
Issues related to the taxation of foreign earnings of U.S. multinational corporations H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes.  In particular, execution of the kidney education and bundling provisions. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. 
H.R.1:  The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to 
comparative effectiveness research.
H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes.
H.R.2502 : To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes.
S. 1679: An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. 
H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans
H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree.
"America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices.
Drug and device marketing and promotion
Drug and biological product pricing and reimbursement
Drug and biological product pricing and reimbursement
Healthcare-acquired infections
Issues regarding 340B
Lifetime caps for insurance
Medical product safety
Prescription drug pedigree and anti-counterfeiting policy H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. 
S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP. H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. 
S.701: A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG). 
"America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices.
H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes.  In particular, execution of the kidney education and bundling provisions. 
Product Payment Issues
Therapy Payment Issues
TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 136 - Centers For Medicare and Medicaid Services (CMS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 136 - Centers For Medicare and Medicaid Services (CMS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 136 - Centers For Medicare and Medicaid Services (CMS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS) 136 - Centers For Medicare and Medicaid Services (CMS) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 39 - State, Dept of (DOS)
BAXTER HEALTHCARE CORPORATION
1501 K STREET, NW, SUITE 375, WASHINGTON, DC, 20006, US
JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JED PERRY JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) JED PERRY JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JACK MANIKO (Counsel, House Cmte on Energy & Commerce) KELLI MILLS LESTER JED PERRY DEBORAH WILLIAMS (Prof. Staff, House Committee on Ways & Means) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce) SARAH CREVISTON JACK MANIKO (Counsel, House Cmte on Energy & Commerce) KELLI MILLS LESTER JED PERRY DEBORAH WILLIAMS (Prof. Staff, House Committe on Ways & Means) JOSEPH V SCHWAN (Deputy Chief of Staff, U.S. Dept of Commerce)
Deputy Chief of Staff, U.S. Dept of Commerce Deputy Chief of Staff, U.S. Dept of Commerce Deputy Chief of Staff, U.S. Dept of Commerce Counsel, House Cmte on Energy & Commerce Prof. Staff, House Committee on Ways & Means Deputy Chief of Staff, U.S. Dept of Commerce Counsel, House Cmte on Energy & Commerce Prof. Staff, House Committe on Ways & Means Deputy Chief of Staff, U.S. Dept of Commerce